Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Extracytoplasmic stress responses induced by antimicrobial cationic polyethylenimines.

Lander BA, Checchi KD, Koplin SA, Smith VF, Domanski TL, Isaac DD, Lin S.

Curr Microbiol. 2012 Nov;65(5):488-92. Epub 2012 Jul 14.

3.

The role of cytochrome 2B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins.

Domanski TL, He YQ, Scott EE, Wang Q, Halpert JR.

Arch Biochem Biophys. 2001 Oct 1;394(1):21-8.

PMID:
11566023
4.

Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity.

Domanski TL, He YA, Khan KK, Roussel F, Wang Q, Halpert JR.

Biochemistry. 2001 Aug 28;40(34):10150-60.

PMID:
11513592
5.

Identification and functional characterization of eight CYP3A4 protein variants.

Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L.

Pharmacogenetics. 2001 Jul;11(5):447-58.

PMID:
11470997
6.

Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis.

Domanski TL, Halpert JR.

Curr Drug Metab. 2001 Jun;2(2):117-37. Review. Erratum in: Curr Drug Metab 2001 Dec;2(4):425.

PMID:
11469721
7.

Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation.

Xue L, Wang HF, Wang Q, Szklarz GD, Domanski TL, Halpert JR, Correia MA.

Chem Res Toxicol. 2001 May;14(5):483-91.

PMID:
11368545
8.

cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450.

Domanski TL, Finta C, Halpert JR, Zaphiropoulos PG.

Mol Pharmacol. 2001 Feb;59(2):386-92.

PMID:
11160876
9.

Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity.

Domanski TL, He YA, Harlow GR, Halpert JR.

J Pharmacol Exp Ther. 2000 May;293(2):585-91.

PMID:
10773032
10.

Structure-function analysis of human cytochrome P-450 2B6 using a novel substrate, site-directed mutagenesis, and molecular modeling.

Domanski TL, Schultz KM, Roussel F, Stevens JC, Halpert JR.

J Pharmacol Exp Ther. 1999 Sep;290(3):1141-7.

PMID:
10454488
11.

Use of the steroid derivative RPR 106541 in combination with site-directed mutagenesis for enhanced cytochrome P-450 3A4 structure/function analysis.

Stevens JC, Domanski TL, Harlow GR, White RB, Orton E, Halpert JR.

J Pharmacol Exp Ther. 1999 Aug;290(2):594-602.

PMID:
10411567
12.

Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.

Halpert JR, Domanski TL, Adali O, Biagini CP, Cosme J, Dierks EA, Johnson EF, Jones JP, Ortiz de Montellano P, Philpot RM, Sibbesen O, Wyatt WK, Zheng Z.

Drug Metab Dispos. 1998 Dec;26(12):1223-31. Review.

PMID:
9860932
13.
14.

Transcription analysis of the Staphylococcus aureus gene encoding penicillin-binding protein 4.

Domanski TL, de Jonge BL, Bayles KW.

J Bacteriol. 1997 Apr;179(8):2651-7.

15.

Supplemental Content

Loading ...
Support Center